Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516407 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Electronic (PDF)Add to Basket
Hard CopyAdd to Basket
EnterprisewideAdd to Basket
Live Chat Live Help Software for Website

China Pharmaceutical Industry: Analysis and Market Trends

Pharma-Reports, Sep 2011, Pages: 91


  Description  
   Table of Contents   
   Companies Mentioned   
    
    
     
  Enquire before Buying   
  Send to a Friend   

The pharmaceutical industry is one of the leading industries in China, covering synthetic chemicals and drugs, prepared Chinese medicines, medical devices, apparatus and instruments, hygiene materials, packing materials, and pharmaceutical machinery.

This report examines the Chinese Pharmaceutical Industry in-depth and focuses on the impact the WTO accession of China has had on the Chinese pharmaceutical industry, trends, and competition.

China accounts for 20% of the world's population but only 1.5% of the global drug market. China's changing healthcare environment is designed to extend basic health insurance to a larger portion of the population and give individuals greater access to products and services. The Chinese pharmaceutical industry is expected to continue its expansion.

The domestic China pharmaceutical market is highly fragmented and inefficient. Adverse factors include a lack of protection of intellectual property rights, a lack of visibility for drug approval procedures, a lack of effective governmental incentives, poor corporate support for drug research, and differences in the treatment in China accorded to local and foreign firms.

Even so, the industry environment has been transformed for the better over the last 10 years. Entry to the WTO has brought a stronger patent system, medical insurance is now more widespread, and pharmaceutical-related regulations have been stiffened. China is reportedly expected to become the third largest pharmaceuticals market in the world by 2011.

Research and development is rapidly increasing with Shanghai becoming one of the most important global centers. Most notably, Novartis is expected to establish a large R&D base in Shanghai that will be a pillar of its drug development.

The report also analyzes the Chinese pharmaceutical industry through a SWOT analysis and a PEST analysis. The report looks at the investment scenario in the Chinese pharmaceutical industry and the role of the government in the industry and other factors.

A look at the top market players in the Chinese pharmaceutical industry completes this research report.



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds